Briefing Sales Surge PolyNovo posts 26% rise in first-half sales amid 'significant' US policy changes 19 January 2026
Briefing Trials and Tribulations PolyNovo says chronic wound treatment more effective than clinical standard alone 12 September 2025
Briefing Index Slump Smartgroup, PolyNovo, Amotiv lead losses ahead of removal from ASX 200 8 September 2025
Briefing Competitive Boost PolyNovo set to benefit from proposed US medicare changes 2 September 2025
Briefing Skin-vestments PolyNovo in trading halt ahead of response to US health spend crackdown 1 September 2025
Briefing Tissue Growth Polynovo FY25 earnings expected to at least three times higher year on year 29 July 2025
Briefing Salt In The Wound PolyNovo shares tumble as Morningstar says stock 'overvalued' 25 February 2025
